List of insiders holdings for INVIVO THERAPEUTICS HLDGS CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
LANGER ROBERT 10% Owner | 2013-06-05 17:56:44 | 7,433,628 0 | 7,433,628 | Form 4 |
KIMBERLIN KEVIN 10% Owner | 2010-12-08 17:59:19 | 7,187,321 0 | 7,187,321 | Form 13G |
Coker Peter L. Secretary 10% Owner | 2009-06-17 13:10:59 | 3,275,000 3,793,457 | 7,068,457 | Form 5 |
REYNOLDS FRANCIS 10% Owner | 2015-02-03 14:26:35 | 4,913,260 0 | 4,913,260 | Form 13D |
Reichard Peter Chief Executive Officer 10% Owner | 2009-06-17 13:14:15 | 3,275,000 0 | 3,275,000 | Form 5 |
Wirth Edward Chief Science Officer | 2011-12-07 14:59:47 | 775,000 0 | 775,000 | Form 4 |
Coker Peter L Secretary | 2006-06-30 17:47:36 | 518,457 0 | 518,457 | Form 3 |
PERRIN MARK D CHIEF EXECUTIVE OFFICER | 2017-01-20 14:04:18 | 320,000 0 | 320,000 | Form 4 |
Ulich Thomas R Chief Scientific Officer | 2017-01-20 14:03:48 | 150,000 0 | 150,000 | Form 4 |
JOSEPH TAMARA L SVP, General Counsel | 2017-01-20 14:05:14 | 120,000 0 | 120,000 | Form 4 |
ASTRUE MICHAEL J INTERIM CEO | 2014-01-13 17:56:11 | 108,848 0 | 108,848 | Form 4 |
HESS BRIAN Chief Technology Officer | 2013-12-20 16:47:32 | 75,000 0 | 75,000 | Form 4 |
Toselli Richard M. CEO and CMO | 2022-11-21 17:04:49 | 61,000 0 | 61,000 | Form 4 |
Moran Sean F. Acting Chief Financial Officer | 2013-09-04 10:48:21 | 60,000 0 | 60,000 | Form 4 |
NOLEN GEORGE Director | 2013-01-02 16:31:15 | 50,000 0 | 50,000 | Form 4 |
STERN ADAM K Director | 2012-12-18 19:54:20 | 50,000 0 | 50,000 | Form 4 |
PEDRA CHRISTI Director | 2011-12-12 16:21:23 | 50,000 0 | 50,000 | Form 4 |
STAHL PAMELA J Chief Commercial Officer | 2017-01-20 14:04:43 | 35,000 0 | 35,000 | Form 4 |
McNulty Christopher Chief Financial Officer | 2017-03-31 15:09:09 | 29,973 0 | 29,973 | Form 4 |
PERRY GREGORY D Interim CFO | 2014-01-02 16:35:39 | 22,374 0 | 22,374 | Form 4 |
CHRISTOPHER RICHARD Chief Financial Officer | 2022-11-21 17:05:37 | 20,800 0 | 20,800 | Form 4 |
MCALLISTER STEVEN F Chief Financial Officer | 2016-01-22 19:35:08 | 19,160 0 | 19,160 | Form 5 |
Hamel Heather Chief Legal Officer and GC | 2022-11-21 17:02:53 | 13,400 0 | 13,400 | Form 4 |
MCCARTHY JOHN A JR Director | 2015-12-11 17:23:00 | 12,500 0 | 12,500 | Form 4 |
DiPietro Kenneth Director | 2018-01-23 19:21:17 | 12,500 0 | 12,500 | Form 4 |
Hatfield Jeffrey S. Director | 2018-01-23 21:22:11 | 12,500 0 | 12,500 | Form 4 |
Golarz Melanie Interim CFO | 2017-01-10 11:01:25 | 7,500 0 | 7,500 | Form 3 |
Morrison Christina Director | 2022-11-21 17:00:44 | 4,200 0 | 4,200 | Form 4 |
MERRIFIELD C ANN Director | 2022-11-21 17:02:06 | 4,200 0 | 4,200 | Form 4 |
MARSHAK DANIEL R Director | 2022-11-21 17:02:39 | 4,200 0 | 4,200 | Form 4 |
ROBERTS RICHARD JOHN Director | 2022-11-21 17:03:18 | 4,200 0 | 4,200 | Form 4 |
ROSENTHAL BOB Director | 2022-11-21 17:04:11 | 4,200 0 | 4,200 | Form 4 |
Lorianne Masuoka K. Chief Medical Officer | 2016-01-22 19:34:05 | 265 0 | 265 | Form 5 |
Modestino Jeffrey See Remarks | 2018-05-18 16:55:10 | 0 0 | 0 | Form 3 |
Reichard Peter A President, CEO | 2006-06-30 14:23:30 | 0 0 | 0 | Form 3 |
Foose Brice 10% Owner | 2024-02-07 14:12:16 | 0 0 | 0 | Form 4/A |